Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Recs

0
Player Avatar danbeachler (94.02) Submitted: 9/26/2006 11:46:50 PM : Outperform Start Price: $15.34 REGN Score: +756.39

I was impressed by the company when i interviewed with them. lots of drugs in the pipeline

Report this Post 1 Comment
Member Avatar js22222 (84.20) Submitted: 10/17/2006 10:13:52 PM
Recs: 0

Haha dan loves drugs

Report this Post

Featured Broker Partners


Advertisement